MODIFIED BIORELATED SUBSTANCE, METHOD FOR MANUFACTURING THE SAME, AND ITS INTERMEDIATE

PROBLEM TO BE SOLVED: To provide a biorelated substance modified by bonding with a polyalkylene glycol derivative, a method for manufacturing it and a polyalkylene glycol derivative being an intermediate. SOLUTION: The modified biorelated substance is a substance having in the molecule a bond with a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SAKAGAMI KENJI, OHASHI SHUNSUKE, ITOU TOMOYOSHI, YAMAMOTO YUJI, NAKAMOTO KENICHIRO, YASUKOCHI TORU
Format:	Patent
Sprache:	eng
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY COMPOSITIONS BASED THEREON HUMAN NECESSITIES HYGIENE MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONSONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY ORGANIC MACROMOLECULAR COMPOUNDS PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS THEIR PREPARATION OR CHEMICAL WORKING-UP
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PROBLEM TO BE SOLVED: To provide a biorelated substance modified by bonding with a polyalkylene glycol derivative, a method for manufacturing it and a polyalkylene glycol derivative being an intermediate. SOLUTION: The modified biorelated substance is a substance having in the molecule a bond with at least one polyalkylene glycol oxy group expressed by formula (1). In formula (1), R is a 1-24C hydrocarbon group; OA1and OA2are each a 2-4C oxyalkylene group; R and OA2are the same or different in one molecule; n and m are each an average additive mole number of the oxyalkylene group; n is 0-1,000; and m is 10-1,000. COPYRIGHT: (C)2004,JPO&NCIPI